Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention ― Post Hoc Analysis of HINODE ―
Circulation Journal · 25.06.2024 · 88 (7) · 1118-1124
DOI: 10.1253/circj.cj-23-0801 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, erschienen am 25.06.2024. Verfasst von Yoshinari Enomoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Toho University Ohashi Medical Center. Hauptthemen laut MEDLINE: Heart Failure, Defibrillators, Implantable, Cardiac Resynchronization Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Despite an increased incidence of chronic heart failure (HF) and sudden cardiac death (SCD), the use of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) is much lower in Japan than in Western countries. The HF Indication and SCD Prevention Trial Japan (HINODE) prospectively assessed the mortality rate, appropriately treated ventricular arrhythmias (VA), and HF in Japanese patients with a higher risk of HF. METHODS AND RESULTS: HINODE consisted of ICD, CRT-defibrillator (CRT-D), pacing, and non-device treatment cohorts. This subanalysis evaluated the impact of the implantation of high-voltage devices (HVD; ICD and CRT-D) in 171 Japanese patients. We compared all-cause mortality, VA, and HF events between elderly (age >70 years at study enrollment) and non-elderly HVD recipients. The estimated survival rate through 24 months in the HVD cohort was 85.8% (97.5% lower control limit 77.6%). The risk of all-cause mortality was increased for the elderly vs. non-elderly (hazard ratio [HR] 2.82; 95% confidence interval [CI] 1.01-7.91; P=0.039), but did not differ after excluding ICD patients with CRT-D indication (HR 2.32; 95% CI 0.79-6.78; P=0.11). There were no differences in VA and HF event-free rates between elderly and non-elderly HVD recipients (P=0.73 and P=0.55, respectively). CONCLUSIONS: Although elderly patients may have a higher risk of mortality in general, the benefit of HVD therapy in this group is comparable to that in non-elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.
- Division of Cardiology, National Center for Global Health and Medicine Hospital.
- Division of Cardiovascular Medicine, Toho University Faculty of Medicine.
- Division of Cardiology, Odawara Cardiovascular Hospital.
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.
- Boston Scientific Corporation.
Zitieren
APA
Enomoto, Y., Ikeda, T., Nakamura, K., Noro, M., Sugi, K., Moroi, M., Nakamura, M., Kusano, K., Schwartz, T., Kayser, T., & Aonuma, K. (2024). Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention ― Post Hoc Analysis of HINODE ―. Circulation Journal, 88(7), 1118-1124. https://doi.org/10.1253/circj.cj-23-0801
Vancouver
Enomoto Y, Ikeda T, Nakamura K, Noro M, Sugi K, Moroi M, et al. Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention ― Post Hoc Analysis of HINODE ―. Circulation Journal. 2024;88(7):1118-1124. doi:10.1253/circj.cj-23-0801
BibTeX
@article{Enomoto2024,
author = {Enomoto, Yoshinari and Ikeda, Takanori and Nakamura, Keijiro and Noro, Mahito and Sugi, Kaoru and Moroi, Masao and Nakamura, Masato and Kusano, Kengo and Schwartz, Torri and Kayser, Torsten and Aonuma, Kazutaka},
title = {Impact of High-Voltage Device Implantation in Elderly Japanese Patients With Heart Failure as Primary Prevention ― Post Hoc Analysis of HINODE ―},
journal = {Circulation Journal},
year = {2024},
volume = {88},
number = {7},
pages = {1118--1124},
doi = {10.1253/circj.cj-23-0801}
}
EUVIMED